Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer

• Akinori Sasaki

• Yoshiaki Nakamura

• Saori Mishima

• Akihito Kawazoe

• Yasutoshi Kuboki

• Hideaki Bando

• Takashi Kojima

• Toshihiko Doi

• Atsushi Ohtsu

• Takayuki Yoshino

• Takeshi Kuwata

• Tetsuo Akimoto

• Kohei Shitara

Journal

• Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編]

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編] 22 (4), 793-802, 2019

  Tokyo : Springer Japan

Keywords

• Nivolumab
• PD-1 inhibitor
• Gastric cancer
• Hyperprogressive disease

Details

• CRID: 1523388080282412416
• NII Article ID: 40021925994
• NII Book ID: AA11316227
• ISSN: 14363291
• NDL BIB ID: 029757529
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I029757529
• Web Site: https://search.jamas.or.jp/link/ui/2020221916
• Text Lang: en
• NDL Source Classification:
  • ZS34(科学技術--医学--腫瘍・癌)
• Data Source:
  • NDL
  • CiNii Articles